Fresenius | FRE - Fremdkapital

Aktienkurs
39.07
Täglich Wechseln
-0.84 -2.10%
Monatlich
-4.03%
Jährlich
-9.46%
Q2 Prognose
37.79




Fremdkapital Veränderung Datum
Akzo Nobel EUR 4.76B 1.09B 2026-03
Alcon AG USD 4.16B 434M 2026-03
AstraZeneca USD 25.96B 177M 2026-03
BASF EUR 18.48B 447M 2025-12
Bayer EUR 30.68B 1.15B 2026-03
Beiersdorf EUR 117M 15M 2025-12
DaVita Healthcare Partners USD 10.51B 349.61M 2026-03
Demant DKK 18.98B 3.71B 2025-12
E.ON EUR 36.53B 2.47B 2026-03
Essilor EUR 9.46B 92M 2025-12
Fresenius EUR 9.22B 1.58B 2025-12
Fresenius Medical Care EUR 5.74B 895.27M 2026-03
Getinge SEK 8.92B 640M 2025-12
Givaudan CHF 4.19B 448M 2025-12
GlaxoSmithKline GBP 14.01B 696M 2026-03
GN Store Nord DKK 8.1B 790M 2026-03
GRIFOLS EUR 9.08B 612M 2026-03
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Lonza CHF 3.88B 323M 2025-12
Merck EUR 10.8B 72M 2026-03
Novartis USD 37.45B 7.86B 2026-03
Philips EUR 6.89B 43M 2026-03
Roche Holding CHF 27.43B 966M 2025-12
RWE EUR 16.43B 917M 2026-03
Sanofi EUR 13.84B 1.88B 2026-03
Smith & Nephew USD 3.3B 22M 2025-12